Skip to main content
Download PDF

Vitamin D deficiency and metabolic syndrome in elderly Chinese individuals: evidence from CLHLS

Nutrition & Metabolism volume 17, Article number: 58 (2020) Cite this article

Abstract

Objectives

Both low vitamin D status and metabolic syndrome (MetS) are worldwide concerns, and low 25-hydroxyvitamin D [25(OH)D] levels are associated with MetS; however, related epidemiological evidence based on elderly Chinese individuals, especially those over 80 years of age, is limited. In the present study, we aimed to evaluate the association between serum 25(OH)D and MetS in elderly Chinese individuals.

Method

Serum 25(OH)D was measured in a cross-sectional sample of 2493 elderly people aged 65–112 years from eight areas of China in which the density of centenarians is exceptionally high. MetS was diagnosed according to blood pressure, lipid, and blood sugar levels; waist circumference; and body mass index (BMI). Adjusted multivariable logistic regression was used to analyze the associations between vitamin D and MetS based on different diagnostic criterias.

Results

A total of 890 (35.7%) of the recruited elderly individuals had insufficient levels of vitamin D, and 1029 participants (41.3%) were vitamin D deficient. High serum vitamin D concentrations were associated with a low prevalence of MetS according to the modified Adult Treatment Panel III (ATP III) criteria for adequate versus deficient vitamin D levels (OR: 0.63, 95% CI: 0.45, 0.88) and inadequate versus deficient vitamin D levels (OR: 0.70, 95% CI: 0.52, 0.92). Each 10 ng/ml increase in serum vitamin D was significantly associated with a decreased prevalence of MetS according to the modified ATP III criteria for people with normal waist circumference (WC) (OR: 0.55, 95% CI: 0.43,0.71). However, no significant statistical correlation was found among elderly people with a high WC. Additionally, in the analysis of the individual components, the ORs of adequate versus deficient vitamin D levels were 0.46 (95% CI: 0.30, 0.71) for elevated triglycerides and 0.64 (95% CI: 0.42, 0.97) for reduced high-density lipoprotein cholesterol (HDL-C) after adjustment for other components.

Conclusions

Vitamin D deficiency is very common among elderly Chinese individuals. Vitamin D deficiency may be a risk factor for MetS; however, the association was only statistically significant among elderly people with noncentral obesity. Further studies are needed to examine the causal direction of the association.

Introduction

As a fat-soluble vitamin, vitamin D is traditionally thought to regulate the metabolism of calcium and phosphorus in the body. However, emerging data suggest that vitamin D levels are also closely associated with many nonskeletal diseases, including cancer, infection, cardiovascular disease and metabolic syndrome (MetS) [1,2,3,4]. Vitamin D deficiency, which is a highly prevalent condition, has become a worldwide concern. Several large epidemiological studies have shown that vitamin D deficiency occurs in approximately 30 to 50% of the general population [5]. The prevalence of vitamin D deficiency among elderly Chinese individuals is even higher than that in other countries, at 79.7% in women and 64.0% in men [6]. With the increase of life expectancy per capita and the aggravation of global aging, he health conditions of and preventive health care for the elderly population are becoming increasingly important. Therefore, it is important to explore the health effects of vitamin D deficiency on elderly Chinese individuals.

MetS is a group of clinical syndrome characterized by insulin resistance, diabetes or impaired glucose regulation, obesity, abnormal lipid metabolism, hypertension and other metabolic diseases. The prevalence of MetS among elderly Chinese individuals increased from 50.4% in 2001 to 58.1% in 2010 [7]. Studying the risk factors for MetS, which is usually recognized as an important predictor of cardiovascular and cerebrovascular diseases and diabetes mellitus, is of great significance for improving the health condition of the population, especially that of the elderly population.

Several epidemiological studies have found that serum vitamin D levels are inversely associated with MetS in both Western and Asian populations [8,9,10,11,12]. Animal models and in vitro studies have revealed some relevant mechanisms of action of vitamin D on metabolic syndrome [13]. However, the results of epidemiological studies on the associations between serum vitamin D deficiency and MetS are inconsistent. In addition, many of the studies included only people younger than 60 years, and few of them focused on elderly individuals, especially people older than 80 years, which is the group with the highest prevalence of vitamin D deficiency and MetS [10, 14]. Because the study population of the only study focusing on an elderly Chinese population was selected from one or two of the most developed cities in China [9, 12], it is difficult for the results to be generalized to elderly individuals in other parts of China. Our study aimed to examine the relationship between vitamin D and MetS in eight longevity regions of eight provinces in China.

Methods

Study population

Data were based on the Chinese Longitudinal Healthy Longevity Survey (CLHLS), a community-based study designed to assess the health status and its influencing factors in elderly populations in longevity regions. In 2017, a biomarker substudy of the 2017–2018 CLHLS was conducted in eight longevity regions, including Xiayi County of Henan Province, Zhongxiang City of Hubei Province, Laizhou City of Shandong Province, Yongfu County of Guangxi Autonomous Area, Sanshui District of Guangdong Province, Mayang County of Hunan Province, Chengmai County of Hainan Province and Rudong County of Jiangsu Province. These eight areas are distributed across northern and southern China. Individuals aged 65 years and older (N = 2493) were recruited, and blood samples were obtained. The study was approved by the biomedical ethics committee of Peking University (IRB00001052–24713074). All participants signed written informed consent forms.

Data collection

We collected information using a standardized questionnaire administered during an in-home interview. The information included demographic data such as age, gender, nationality, residential region, education level, marital status and health-related lifestyle information, such as current smoking, current alcohol consumption, physically active and medical conditions including self-reported diabetes and self-reported hypertension. We also recorded the sampling season for each participant. After the in-home interview, all participants were asked to undergo anthropometric measurements, which included height, weight, waist circumference (WC), hip circumference and two blood pressure measurements with at least a one-minute interval between them. Waist measurements were taken early in the morning on an empty stomach. The participants were asked to stand upright and relax his abdomen with gently breath. After having rested for 5 min under supervision of trained research assistants, arterial blood pressure was measured with mercury sphygmomanometer on the right arm at heart level of the seated subject. We would measure WC and SBP and DBP twice and take the mean value of each index. According to the criteria for Chinese individuals, we categorized body mass index (BMI) into two groups [15]: underweight and normal weight (< 24.0 kg/m2) or overweight or obese (≥24.0 kg/m2).

Biochemical measurements

Fasting venous blood was collected in a 5 ml heparin anticoagulant vacuum tube and centrifuged at 20 °C and 2500 rpm. The plasma was isolated and frozen at − 20 °C, shipped in cold storage to the central laboratory at Capital Medical University in Beijing, and stored at − 80 °C until analysis.

Fasting plasma glucose, serum total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C) and serum hemoglobin were measured using an automatic biochemistry analyzer (7180; Hitachi, Swiss Roche Company). The plasma glucose level was measured by the glucose oxidase method. The serum total cholesterol level was measured by the cholesterol oxidase method. The serum triglyceride level was measured by the glycerol phosphate oxidase-peroxidase method. Serum hemoglobin was measured by enzyme colorimetry.

Assessments of vitamin D status

An enzyme-linked immunosorbent assay (Immunodiagnostic Systems Limited, Bolton, UK) was used to measure plasma 25-hydroxyvitamin D [25(OH)D] levels, and the inter- and intra-assay coefficients of variation were less than 10 and 8%, respectively. Serum vitamin D levels were defined as “sufficient” (25(OH)D ≥ 30 ng/mL), “insufficient” (20 ≤ 25(OH)D < 30 ng/mL), or “deficient” (< 20 ng/mL) [16].

Classification of MetS

ATP III recommended obesity be the primary target of intervention for metabolic syndrome. First-line therapy should be weight reduction reinforced with increased physically active. Weight loss can lower serum cholesterol and triglycerides, blood pressure and glucose, and raise HDL cholesterol, and reduce insulin resistance. We used the following three ethnicity-specific MetS criteria to compute the prevalence of MetS and study the relationship between vitamin D level and MetS [17]: (1) the Adult Treatment Panel III of the National Cholesterol Education Program (ATP III) guidelines, modified in accordance with the World Health Organization (WHO)‘s proposed WC cutoff points for Asians (modified ATP III) [18], (2) the Chinese Diabetes Society (CDS) criteria [19], and (3) the modified CDS criteria (2012) [20] (Tables 1 and 2). The modified ATP III guidelines have been widely used in the study of the relationship between vitamin D and MetS in various countries. The CDS criteria were applicable diagnostic criteria for the Chinese population based on the study of MetS in China, which was proposed by the Diabetes Society of the Chinese Medical Association in 2004. The modified criteria (2012) is a simplified “modified” explanatory model to predict MetS by differentially examining the risk of cardiometabolic syndrome in Asians. Increased WC plus one other MetS component was required for diagnosis [20].

Table 1 Definition of metabolic syndrome
Full size table
Table 2 Basic characteristics of the study subjects
Full size table

Statistical analysis

Continuous variables are presented as means ± SDs and were analyzed with one-way ANOVA. Categorical variables are presented as percentages and were analyzed with the chi-square test. Logarithmic transformation was applied when the continuous variables did not conform to a normal distribution.

The variables were categorized as follows: age was stratified into 10-year periods, and waist-hip ratio was classified as < 0.9 or ≥ 0.9 for males and < 0.85 or ≥ 0.85 for females [21]. BMI was classified as < 24.0 or ≥ 24.0 kg/m2. Multivariate logistic regression analyses were performed to investigate the association between vitamin D status and MetS. Adjustments were made for age, sex, education level (0, 1–9 or ≥ 10 years), marital status (married or single), race (Han or other ethnic minority), BMI (< 24.0 kg/m2 or ≥ 24 .0 kg/m2), current smoking (yes or no), current alcohol consumption (yes or no), and regular physically active (yes or no). We did not consider the blood sample collection season because almost all of our samples were collected from September to November, which is autumn in China. Two models were applied for each outcome: the basic model (adjusted for age and sex) and model 2 (basic model plus marital status and health-related lifestyle factors such as smoking, alcohol consumption, physically active and BMI). We mainly explored the relationship between vitamin D and MetS according to the modified ATP III guidelines for MetS to allow for comparisons with other similar studies. We also explored the relationship between vitamin D and MetS based on two other MetS diagnostic criteria. The associations between vitamin D status and individual components of MetS were investigated with the full model, and the associations between vitamin D status and individual components of MetS were further tested with a multivariate model after further adjustment for the remaining components of MetS.

To evaluate the robustness of our results, we conducted sensitivity analyses by individually excluding some participants (if they suffered from multiple diseases, had inadequate mobility, or were under 80 years old) from the model. All statistical tests were two-tailed, with an alpha = 0.05 level of significance, and were performed using SAS 9.4 software (SAS Institute Inc., Cary, NC).

Results

Baseline characteristics of the study population

The present study population was composed of 2493 participants, with an average age of 85 years, and included 1559 elderly people over the age of 80 years old, accounting for 62.5% of all the subjects, and consisted of 1197 males and 1296 females. The proportions of people with vitamin D insufficiency (20 ≤ 25(OH)D < 30 ng/mL) and vitamin D deficiency (25(OH)D < 20 ng/ml) were 35.7 and 41.3%, respectively. Their average age was 85.7 years, which was older than that of the vitamin D-sufficient group (p < 0.01). The average age of MetS according to ATP III,2012 and CDS was 85, 85 and 82 years old respectively. The level of vitamin D in elderly individuals over 100 years old was 17.95 ng/ml. The level of vitamin D of MetS according to ATP III,2012 and CDS was 22.3,22.9 and 21.7 ng/ml respectively. The other characteristics of the total study population are shown in Tables 1 and 2. The vitamin D level of people with MetS based on the modified ATP III criteria but without MetS based on the modified criteria (2012) was 21.2 ng/ml, which was significantly lower than that of individuals with MetS based on the modified criteria (2012) but without MetS based on the modified ATP III criteria (23.6 ng/ml). The ages of these two groups were 84 and 85 years, respectively. The other characteristics of different group classified based on a combination of different diagnostic criteria are shown in Fig. 1.

Fig. 1
figure 1

Ages and vitamin D levels of subjects with MetS based on different diagnostic criterias. Notes:group1: Non-metabolic syndrome population;group2: MetS based on modified ATP III while without MetS based on modified criteria (2012); group3: MetS based on modified criteria (2012) while without MetS based on modified ATP III;group4:MetS based on both modified ATP III and Modified Criteria (2012)

Full size image

There was no significant difference in systolic blood pressure or HDL-C among the vitamin D-sufficient group, the vitamin D-insufficient group and the vitamin D-deficient group (p > 0.05). The weight, height, triglyceride levels, fasting blood sugar and WC were significantly different among the three groups (p < 0.05). Moreover, there were significant differences in the waist-hip ratio among the three groups (p < 0.05). The percentage of people with an appropriate waist-hip ratio was higher in the vitamin D-sufficient group than in the other two groups. The prevalence of MetS was lowest in the vitamin D-sufficient group and highest in the vitamin D-deficient group regardless of the criteria used for the diagnosis of MetS. The prevalence of MetS according to ATP III,2012 and CDS was 44.4%,51.1 and 27.5% respectively. The difference in the prevalence of MetS based on CDS,ATP III and 2012 was statistically significant between each group (p < 0.01).

The relationship between vitamin D status and MetS

In the analysis of the basic model (model 1), with adjustments for only age and sex, each 10 ng/ml increase in serum 25(OH)D was significantly associated with a decreased prevalence of MetS according to the modified ATP III criteria (OR: 0.92, 95% CI: 0.84, 1.00). After adjusting for other potential confounders, including nationality, education level, marital status, smoking, alcohol consumption, regular physically active and BMI (model 2), the results were still statistically significant (OR: 0.79, 95% CI: 0.69, 0.90). The vitamin D-sufficient group had a lower risk of MetS the vitamin D-deficient group based on model 2 (OR: 0.63, 95% CI: 0.52, 0.92). We applied the same analysis of MetS according to the CDS criteria and the modified criteria (2012). A similar significant relationship between vitamin D levels and MetS based on the CDS criteria was found. No statistically significant association was found between vitamin D levels and MetS based on the modified criteria (2012) (see Table 3 for details).

Table 3 Multiple logistic regression and subgroup analysis for the association of metabolic syndrome based on different diagnostic criterias with vitamin D status
Full size table

The relationships between vitamin D and the individual components of MetS

We also analyzed the relationships of each MetS component and waist-hip ratio with vitamin D. Each 10 ng/ml increase in serum vitamin D was significantly associated with a decreased risk of elevated triglycerides (OR: 0.60, 95% CI: 0.51, 0.71), reduced HDL-C (OR: 0.67, 95% CI: 0.58,0.78) and elevated glucose (OR: 0.88, 95% CI: 0.78, 0.99) based on model 2. The vitamin D-sufficient group had a lower risk of elevated triglycerides (OR: 0.38, 95% CI: 0.25,0.56) and reduced HDL-C (OR: 0.47,95% CI: 0.32, 0.69) than the vitamin D-deficient group based on model 2(see Table 4 for details). After further adjustment for other components of MetS, we still found significant associations between each 10 ng/ml increase in serum 25(OH)D and elevated triglycerides, reduced HDL-C and elevated glucose. The vitamin D-sufficient group had a lower risk of elevated triglycerides (OR: 0.46, 95% CI: 0.30, 0.71) and reduced HDL-C (OR: 0.64, 95% CI: 0.42, 0.97) than the vitamin D-deficient group after further adjustment for other components of MetS (see Table 5 for details).

Table 4 Multiple logistic regression for the association of individual Components of metabolic syndrome with vitamin D status
Full size table
Table 5 Multiple logistic regression for the association of individual Components of metabolic syndrome with vitamin D status after adjustment of the other MetS components
Full size table

Sensitivity analysis

Table 6 shows the results of the sensitivity analyses. When individually excluding participants (if they suffered from multiple diseases, had inadequate mobility, or were younger than 80 years old) from the model, the estimates of the ORs for vitamin D and MetS remained statistically significant and were very similar to the estimates in the main analyses.

Table 6 Sensitivity analysis for the association of metabolic syndrome based on different diagnostic criterias with vitamin D status
Full size table

Discussion

We found that vitamin D deficiency was significantly associated with an increased risk of MetS based on the modified ATP III criteria and CDS criteria in elderly individuals. However, we did not find any statistical association between vitamin D deficiency and MetS based on the modified criteria (2012). We also found that vitamin D deficiency was inversely associated with the prevalence of elevated serum triglycerides and reduced HDL-C. No significant association was found between vitamin D deficiency and other components of MetS.

The majority of previous studies on the relationship of vitamin D with MetS among Chinese populations focused on middle-aged and elderly people, with an average age younger than 60 years [12, 22]. Some similar studies in other countries included those conducted in the United States [10] and the Netherlands [23], with average participant ages of 73.5 years and 71.2 years, respectively. The average age of our subjects was 85.2 years old. MetS is associated with a variety of adverse health outcomes, including type 2 diabetes, cardiovascular disease, cancer and so on, which affect life expectancy in elderly individuals [24,25,26]. Among the elderly population, especially longaevous individuals, there are great differences in metabolic capacity, living habits, such as outdoor exercise time, and activity ability between elderly individuals and those younger than 60 years [10]. Moreover, with increasing age among the elderly, the ability to absorb and metabolize vitamin D decreases and body fat gradually accumulates, increasing the distributed volume and decreasing the biological activity of fat-soluble vitamin D in obese people [27]. Therefore, there are some characteristics of the relationship between vitamin D and MetS among the elderly and longevity groups that have been studied for the first time.

We also found that vitamin D deficiency and insufficiency were very common in the oldest-old adults; with increased age, serum vitamin D levels decrease. The serum vitamin D levels in elderly individuals over 100 years old was much lower than that reported among Chinese elderly individuals in Shanghai by Wei [12] in 2014, even though our sample collection occurred mainly concentrated in autumn when serum vitamin D levels are relatively high. This figure was slightly higher than 16.06 ng/ml in Chinese elderly individuals, as reported by Ling [9] and was similar to the level in those at an average age of 79 years in Taiwan [28]. The prevalence of vitamin D deficiency and insufficiency was 41.3 and 35.7%, respectively, which was lower than previously reported results [9, 10, 23] and was especially lower than the results of the study conducted in Lanzhou, China [6]. This deviation may be derived in part from the fact that some of the subjects came from southern provinces in China where serum vitamin D levels are higher than those in the north. In addition, some studies [29] have shown that serum vitamin D was associated with total mortality in the general population. There may be a survivor bias for people over 100 years old who were included in our study.

The most accepted criteria for defining MetS was first proposed by the WHO in 1999 [30]. The major academic groups in the world, including the American Association of Clinical Endocrinologists (AACE) [31], ATP III [18], the Third Report of the National Cholesterol Education Program Expert Panel on Detection, the European Group for the Study of Insulin Resistance (EGIR) [32], and the International Diabetes Federation (IDF) [33], have proposed many different diagnostic definitions of MetS. Whether abdominal obesity should be used as a necessary diagnostic component has always been a topic of debate. The criteria change with varying study duration, demographic area, age and disease prediction ability [34, 35]. We studied the relationship of vitamin D with MetS based on different criteria simultaneously and further explored the causes of the differences.

We selected the latest three MetS criteria, among which WC or BMI criteria were modified in accordance with the WHO’s proposed cutoff points for Asians. The prevalence of MetS according to CDS, ATP III and 2012 were diffierent. We found similar statistical correlations between vitamin D levels and MetS based on the CDS and modified ATP III criteria [6, 8, 10, 11, 13, 14]. There were no significant correlations between vitamin D and MetS based on the modified criteria (2012) or the IDF (results not shown). The results remained the same whether various confounding factors were adjusted for or vitamin D levels were analyzed as continuous variables. A significant correlation between vitamin D and MetS was usually based on the ATP III or modified ATP III criteria in other similar studies [9, 10, 22]. Different diagnostic criteria may focus on different pathological mechanisms. The CDS and modified ATP III criteria include obesity as an equally important component as other components in the diagnosis, assuming that the pathological mechanism of MetS extends from insulin resistance to a syndrome consisting of obesity and adipose tissue metabolic disorders [36]. However, the modified criteria (2012) and the IDF regard WC as a necessary prerequisite, and the remaining components are equally important, which means that the criteria emphasize a pathological mechanism centered on central obesity and is applicable to obesity to groups with disorders of glucose and lipid metabolism. The ability to predict possible adverse outcomes in the future is an important factor that must be considered when proposing diagnostic criteria for MetS. Some previous studies have shown that the ability to predict the risk of cardiovascular disease and type 2 diabetes mellitus associated with MetS diagnosed by the modified ATP III criteria is better than MetS diagnosed considering abdominal obesity a necessary diagnostic criterion. The ATP III criteria clearly identifies the burden of coronary heart disease associated with MetS [37].

We found that the vitamin D level of people with MetS based on the modified ATP III criteria but without MetS based on the modified criteria (2012) was 21.22 ng/ml, which was significantly lower than that of individuals with MetS based on the modified criteria (2012) but without MetS based on the modified ATP III criteria (23.63 ng/ml), so the clustering characteristics of the MetS risk components related to vitamin D level changed in the elderly population. The component analysis revealed that rather than central obesity, vitamin D affected MetS mainly by affecting blood lipid metabolism. More mechanisms and prospective studies are needed to determine which diagnostic criteria are appropriate for different age groups when studying the relationship between vitamin D and MetS.

Some previous studies have shown that there are sex differences in the relationship between vitamin D and MetS [37, 38]. Subgroup analyses were carried out for gender, WC (increased or not) and BMI (increased or not) groups. The results showed that the ORs were similar between the different gender groups and BMI groups (results not shown). This finding may be related to the fact that all the women involved in our study were postmenopausal. A significant statistical correlation was found among elderly people with a normal WC, while no significant statistical correlation was found among elderly people with an increased WC. Vitamin D is a fat-soluble vitamin and is involved in fat metabolism. The lipid components played a very important role in the development of metabolic syndrome. This indicates that difference in fat distribution in the body may affect vitamin D metabolism and the relationship between metabolic syndrome and vitamin D. Some studies [39, 40] have shown that vitamin D deficiency is closely related to body fat content and body fat distribution.

Many studies have found that vitamin D levels are significantly associated with blood lipid levels, and we found that vitamin D levels exhibited a significant correlation with triglycerides and HDL-C. Similarly, Sheena [8] and Vitezova [23] also found that vitamin D levels were negatively correlated with triacylglycerol and positively correlated with HDL-C. First, vitamin D plays a very important role in the formation of HDL-C molecules [41,42,43]. Second, active 25(OH)D metabolites can inhibit low-density lipoprotein cholesterol (LDL-C) deposition by promoting the differentiation of monocytes or macrophages and reducing the release of proinflammatory cytokines. Third, vitamin D can regulate the influx of calcium ions, which leads to a decrease in lipase activity and inhibits lipolysis. Fourth, vitamin D can directly act on the vitamin D receptor of pre-Q adipocytes, regulate the differentiation and metabolism of adipocytes, and stimulate the synthesis and secretion of lipoprotein lipase [44]. Finally, vitamin D can also reduce the synthesis and secretion of parathyroid hormone (PTH), enhance lipolysis activity and improve abnormal lipid metabolism [45,46,47].

Strengths

The study included the oldest population, including elderly people mostly over 80 years of age, to study the comprehensive relationships between vitamin D and MetS. We studied the relationship between vitamin D and MetS based on three MetS diagnostic criteria.

Limitations

There are several limitations to the study. First, the results are based data obtained with a cross-sectional study design. We revealed a link between only vitamin D and MetS but could not ascertain the causality of the result. Second, almost all of our biological samples were collected during the same season, so we could not assess the impact of seasonal factors on outcomes. Third, the relationship between vitamin D and metabolic function may be different in different age groups, so our findings are applicable to only the elderly population. In addition, a significant relationship between vitamin D and triglycerides as well as HDL-C was found, but no further measurement of PTH levels was performed. Finally, we adjusted for potential confounders, but we could not estimate the effects of other unmeasured potential confounding factors.

Conclusions

A significant correlation between vitamin D and MetS in the elderly population in China was found and was significant in those with concealed obesity. Additional attention needs to be paid to the level of vitamin D in the population with normal WC in the context of the prevention and treatment of MetS. Appropriate diagnostic criteria for MetS need to be chosen based on the characteristics of the study population to explore the relationship between vitamin D and MetS in future studies.

Availability of data and materials

This study was based on the datasets from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) in longevity areas. The CLHLS datasets are publicly available at the National Archive of Computerized Data on Ageing (NACDA),University of Michigan(https://www.icpsr.umich.edu/icpsrweb/NACDA/series/487). Researchers can obtain these data after submitting a data use agreement to CLHLS team.

Abbreviations

MetS:

Metabolic syndrome

BMI:

Body mass index

CLHLS:

Chinese Longitudinal Healthy Longevity Survey (CLHLS)

WC:

Waist circumference

HDL-C:

High-density lipoprotein cholesterol

WHO:

The World Helath Orgnization

CDS:

The Chinese Diabetes Society

EGIR:

The European Group for the study of Insulin

IDF:

The International Diabetes Federation

CVD:

Cardiovascular disease

AACE IRS:

American Association of Clinical Endocrinologists

ATP III:

The Adult Treatment Panel III of the National Cholesterol Education Program guidelines

PTH:

Parathyroid hormone

References

  1. Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin N Am. 2012;38(1):161–78.

    Google Scholar 

  2. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12(1):31.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Lu W, Song YQ, JoAnn EM, Stefan P, Winfried M, Karl M, et al. Circulating levels of 25Hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819–29.

    Google Scholar 

  4. Boucher BJ. Is vitamin D status relevant to metabolic syndrome? Dermatoendocrinol. 2012;4(2):212–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Lee JH, O'keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949–56.

    CAS  PubMed  Google Scholar 

  6. Zhen D, Liu L, Guan C, Zhao N, Tang X. High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors. Bone. 2015;71:1–6.

    CAS  PubMed  Google Scholar 

  7. Liu M, Wang J, Jiang B, Sun D, Wu L, Yang S, et al. Increasing Prevalence of Metabolic Syndrome in a Chinese Elderly Population: 2001–2010. PLoS One. 2013;8(6):e66233.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Kayaniyil S, Harris SB, Retnakaran R, Vieth R, Knight JA, Gerstein HC, et al. Prospective association of 25(OH)D with metabolic syndrome. Clin Endocrinol. 2014;80(4):502–7.

    CAS  Google Scholar 

  9. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32(7):1278–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Reis JP, Von MD, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30(6):1549–55.

    CAS  PubMed  Google Scholar 

  11. Verrusio W, Andreozzi P, Renzi A, Musumeci M, Gueli N, Cacciafesta M. Association between serum vitamin D and metabolic syndrome in middle-aged and older adults and role of supplementation therapy with vitamin D. Ann Ist Super Sanita. 2017;53(1):54–9.

    CAS  PubMed  Google Scholar 

  12. Zhu W, Heil DP. Associations of vitamin D status with markers of metabolic health: a community-based study in Shanghai, China. Diabetes Metab Syndr. 2018;12(5):727–32.

    PubMed  Google Scholar 

  13. Awad AB, Alappat L, Valerio M. Vitamin d and metabolic syndrome risk factors: evidence and mechanisms. Crit Rev Food Sci Nutr. 2012;52(2):103–12.

    CAS  PubMed  Google Scholar 

  14. Oosterwerff MM, Eekhoff EM, Heymans MW, Lips P, Van NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clin Endocrinol. 2011;75(5):608–13.

    CAS  Google Scholar 

  15. Zhou BF. The cooperative meta-analysis Group of Working Group on obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pacific J Clin Nutr. 2002;11(suppl):S685–93.

    Google Scholar 

  16. Michael FH. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.

    Google Scholar 

  17. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13–8.

    CAS  PubMed  Google Scholar 

  18. Bk M. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.

    Google Scholar 

  19. Zhou H, Guo ZR, Yu LG, Hu XS, Xu BH, Liu HB, et al. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract. 2010;90(3):319–25.

    PubMed  Google Scholar 

  20. Mccormack DJ, Pabla R, Babu MH, Dykes L, Dale P, Archbold RA, et al. Undiagnosed sleep apnoea syndrome in patients with acute myocardial infarction: potential importance of the STOP-BANG screening tool for clinical practice. Int J Cardiol. 2012;155(2):342–3.

    PubMed  Google Scholar 

  21. Amar J, Chamontin B, Pelissier M, Garelli I, Salvador M. Influence of glucose metabolism on nycthemeral blood pressure variability in hypertensives with an elevated waist-hip ratio: a link with arterial distensibility. AJH. 1995;8(4 Pt 1):426–8.

    CAS  PubMed  Google Scholar 

  22. Kwon HN, Lim H. Relationship between serum vitamin D status and metabolic risk factors among Korean adults with Prediabetes. PLoS One. 2016;11(10):1–12.

    Google Scholar 

  23. Vitezova A, Zillikens MC, Van HT, Sijbrands EJ, Hofman A, Uitterlinden AG, et al. Vitamin D status and metabolic syndrome in the elderly: the Rotterdam study. Eur J Endocrinol. 2015;172(3):327–35.

    CAS  PubMed  Google Scholar 

  24. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640–5.

    CAS  PubMed  Google Scholar 

  25. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

    Google Scholar 

  26. O'neill S, O'driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.

    CAS  PubMed  Google Scholar 

  27. Darren RB, Paul A, Bibiana GB, Tomas MS. Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin Invest Med. 2011;34(6):E377–E84.

    Google Scholar 

  28. Hwang JS, Tsai KS, Cheng YM, Chen WJ, Tu ST, Lu KH, et al. Vitamin D status in non-supplemented postmenopausal Taiwanese women with osteoporosis and fragility fracture. Bio Med Central. 2014;15(1):257–63.

    Google Scholar 

  29. Zhang YP, Wan YD, Sun TW, Kan QC, Wang LX. Association between vitamin D deficiency and mortality in critically ill adult patients:a meta-analysis of cohort studies. Bio Med Central. 2014;18(6):684.

    Google Scholar 

  30. Balkau B, Charles MA, Bell P, Cavallo P, Lalic N, Mingrone G, et al. Comment on the provisional report from the WHO consultation European group for the study of insulin resistance(EGIR). Diabet Med. 1999;16(5):442–3.

    CAS  PubMed  Google Scholar 

  31. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology Position Statement on the Insulin Resistance Syndrome. Endocr Pract. 2003;9(supplement2):5–21.

    Google Scholar 

  32. Marshall MS. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16(5):442–3.

    Google Scholar 

  33. Earl SF. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care. 2005;28(11):2745–9.

    Google Scholar 

  34. Liao DP, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, et al. Multiple metabolic syndrome is associated with lower heart rate variability. Diabetes Care. 1998;21(12):2116–22.

    CAS  PubMed  Google Scholar 

  35. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Schmidt MI, et al. Familial components of the multiple metabolic syndrome:the ARIC study. Diabetologia. 1997;40(8):963–70.

    CAS  PubMed  Google Scholar 

  36. Guo SD. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol. 2014;220(2):T1–T23.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Sarah EV, Niels DP, Tom D, Albert H, Peter JK, Monique MB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–22.

    Google Scholar 

  38. Sung KC, Chang Y, Ryu S, Chung HK. High levels of serum vitamin D are associated with a decreased risk of metabolic diseases in both men and women, but an increased risk for coronary artery calcification in Korean men. Cardiovasc Diabetol. 2016;15(1):112–24.

    PubMed  PubMed Central  Google Scholar 

  39. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88(1):157–61.

    CAS  PubMed  Google Scholar 

  40. Sorkin JD, Vasaitis TS, Streeten E, Ryan AS, Goldberg AP. Evidence for threshold effects of 25-hydroxyvitamin D on glucose tolerance and insulin resistance in black and white obese postmenopausal women. J Nutr. 2014;144(5):734–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res. 2009;50(suppl):S195–200.

    PubMed  PubMed Central  Google Scholar 

  42. Wehmeier KR, Mazza A, Hachem S, Ligaray K, Mooradian AD, Wong NC, et al. Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators. Biochim Biophys Acta. 2008;1780(2):264–73.

    CAS  PubMed  Google Scholar 

  43. Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF, Calvin J. Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women. J Clin Lipidol. 2010;4(2):113–9.

    PubMed  PubMed Central  Google Scholar 

  44. Xue B. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J. 2001;15(13):2527–9.

    CAS  PubMed  Google Scholar 

  45. Muldowney S, Kiely M. Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev. 2011;24(1):1–20.

    CAS  PubMed  Google Scholar 

  46. Hjelmesæth J, Dag H, Aasheim ET, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol. 2009;8(1):1–7.

    Google Scholar 

  47. Pannu PK, Zhao Y, Soares MJ, Piers LS, Ansari Z. The associations of vitamin D status and dietary calcium with the metabolic syndrome: an analysis of the Victorian health monitor survey. Public Health Nutr. 2017;20(10):1785–96.

    PubMed  Google Scholar 

Download references

Acknowledgements

Not Applicable.

Funding

The 8th Wave Chinese Longitudinal Healthy Longevity Survey in 2017 was supported by National Natural Sciences Foundation of China (G030702).

Author information

Authors and Affiliations

  1. National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, #29 Nanwei Road, Xicheng, Beijing, 100050, China

    Ling Liu, Zhaojin Cao, Yingchun Liu, Yuebin Lv, Yingli Qu, Heng Gu, Chengcheng Li, Jiayi Cai, Saisai Ji, Yawei Li, Feng Zhao & Xiaoming Shi

  2. Beijing Municipal Health Commission Information Center, (Beijing Municipal Health Commission Policy Research Center), Beijing, 100034, China

    Feng Lu

Authors
  1. Ling Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaojin Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Feng Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yingchun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuebin Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yingli Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heng Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chengcheng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jiayi Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Saisai Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yawei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Feng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Xiaoming Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Zhaojin Cao and Feng Zhao helped supervise the field activities. Feng Zhao, Feng Lu and Yingchun Liu collected the data. Yuebin Lv and Yingli Qu contributed to data cleaning. Heng Gu, Jiayi Cai, Chengcheng Li, Saisai Ji and Yawei Li conducted CLHLS and directed its implementation, including quality assurance and control, dataset management and analytic strategy. Ling Liu organized and analyzed the data, and wrote the manuscript. Xiaoming Shi and Yuebin Lv revised the manuscript critically for important content. Ling Liu and Yuebin Lv contributed to the conception and design for the study, wrote and resized the manuscript critically for important intellectual content. All authors read and approved the final version to be published. Xiaoming Shi and Feng Zhao are the guarantor of this work.

Corresponding author

Correspondence to Feng Zhao.

Ethics declarations

Ethics approval and consent to participate

The biomedical ethics committee of Peking University approved the study (IRB00001052–13074). All participants signed written informed consent.

Consent for publication

Not Applicable.

Competing interests

The author declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, L., Cao, Z., Lu, F. et al. Vitamin D deficiency and metabolic syndrome in elderly Chinese individuals: evidence from CLHLS. Nutr Metab (Lond) 17, 58 (2020). https://doi.org/10.1186/s12986-020-00479-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12986-020-00479-3

Keywords

Nutrition & Metabolism

ISSN: 1743-7075

Contact us